{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:57:32Z","timestamp":1790542652335,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974361"],"award-info":[{"award-number":["81974361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272768"],"award-info":[{"award-number":["82272768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004476","name":"Chinese Center for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-Young 2023-0286"],"award-info":[{"award-number":["Y-Young 2023-0286"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-HS202202-0104"],"award-info":[{"award-number":["Y-HS202202-0104"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e32996","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T20:02:28Z","timestamp":1718827348000},"page":"e32996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["National and subnational mortality trends of multiple myeloma in China, 2013\u20132020: Empirical evidence from national mortality"],"prefix":"10.1016","volume":"10","author":[{"given":"Xiaosheng","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0367-1411","authenticated-orcid":false,"given":"Weiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e32996_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.heliyon.2024.e32996_bib2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e32996_bib3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the United States","volume":"164","author":"Chihara","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib4","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.heliyon.2024.e32996_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4143\/crt.2021.290","article-title":"Prediction of cancer incidence and mortality in Korea, 2021","volume":"53","author":"Jung","year":"2021","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.heliyon.2024.e32996_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-019-0807-5","article-title":"Incidence and mortality of multiple myeloma in China, 2006-2016: an analysis of the global burden of disease study 2016","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13045-019-0706-9","article-title":"Mortality of lymphoma and myeloma in China, 2004-2017: an observational study","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib8","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1182\/blood-2011-06-358812","article-title":"Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)","volume":"118","author":"Palumbo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e32996_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2014-10-609461","article-title":"Future distribution of multiple myeloma in the United States by sex, age, and race\/ethnicity","volume":"125","author":"Rosenberg","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e32996_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ejh.13530","article-title":"Survival trends in elderly myeloma patients","volume":"106","author":"Jones","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib11","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1200\/JCO.2014.55.1028","article-title":"Multiple myeloma in the older adult: better prospects, more challenges","volume":"32","author":"Wildes","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41375-018-0098-9","article-title":"Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agents","volume":"32","author":"Avet-Loiseau","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.heliyon.2024.e32996_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/CCI.19.00094","article-title":"Frailty in older adults with multiple myeloma: a study of US veterans","volume":"4","author":"Patel","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.heliyon.2024.e32996_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96804-8","article-title":"Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016","volume":"11","author":"Hemminki","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e32996_bib15","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1158\/1055-9965.EPI-19-0389","article-title":"Association of BMI, smoking, and alcohol with multiple myeloma mortality in Asians: a pooled analysis of more than 800,000 participants in the Asia cohort consortium","volume":"28","author":"Ugai","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.heliyon.2024.e32996_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034288","article-title":"Income-related inequities of adult obesity and central obesity in China: evidence from the China health and nutrition survey 1997-2011","volume":"10","author":"Zhou","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.heliyon.2024.e32996_bib17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/ijerph13111112","article-title":"A review of the growth of the fast food industry in China and its potential impact on obesity","volume":"13","author":"Wang","year":"2016","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.heliyon.2024.e32996_bib18","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.3390\/jcm10184179","article-title":"Occupational exposure and multiple myeloma risk: an updated review of meta-analyses","volume":"10","author":"Georgakopoulou","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2024.e32996_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz025","article-title":"Dietary pattern and risk of multiple myeloma in two large prospective US cohort studies","volume":"3","author":"Lee","year":"2019","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.heliyon.2024.e32996_bib20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cam4.3444","article-title":"Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial-ethnic group, United States 2003-2016","volume":"10","author":"Ellington","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.heliyon.2024.e32996_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13083","article-title":"Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival","volume":"102","author":"Turesson","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(14)70282-7","article-title":"Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study","volume":"15","author":"Sant","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood.2019004309","article-title":"Risk factors in multiple myeloma: is it time for a revision?","volume":"137","author":"Corre","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e32996_bib24","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/ijc.33135","article-title":"Changing trend in mortality rate of multiple myeloma after introduction of novel agents: a population-based study","volume":"147","author":"Usui","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e32996_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/bjh.16674","article-title":"Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982-2017","volume":"191","author":"Langseth","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s12094-020-02541-1","article-title":"Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study","volume":"23","author":"Chang-Chan","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.heliyon.2024.e32996_bib27","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Diseases and injuries collaborators: global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024090273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024090273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:40:13Z","timestamp":1790541613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024090273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024090273"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32996","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National and subnational mortality trends of multiple myeloma in China, 2013\u20132020: Empirical evidence from national mortality","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e32996"}}